Published in Gene on June 23, 2004
Multidisciplinary Study of Right Ventricular Dysplasia | NCT00024505
The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer. J Exp Clin Cancer Res (2016) 1.43
Genetics coupled to quantitative intact proteomics links heritable aphid and endosymbiont protein expression to circulative polerovirus transmission. J Virol (2010) 0.97
Genetic bases of arrhythmogenic right ventricular Cardiomyopathy. Heart Int (2006) 0.80
Isthmin inhibits glioma growth through antiangiogenesis in vivo. J Neurooncol (2012) 0.79
Isthmin 1 is a secreted protein expressed in skin, mucosal tissues, and NK, NKT, and th17 cells. J Interferon Cytokine Res (2014) 0.77
Distinct spatiotemporal expression of ISM1 during mouse and chick development. Cell Cycle (2014) 0.77
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res (2005) 3.99
IDEG6: a web tool for detection of differentially expressed genes in multiple tag sampling experiments. Physiol Genomics (2003) 3.26
Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res (2006) 2.95
Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2002) 2.95
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation (2006) 2.81
Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J (2005) 2.56
Novel definition files for human GeneChips based on GeneAnnot. BMC Bioinformatics (2007) 2.32
Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations. Heart Rhythm (2011) 2.11
Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. J Am Coll Cardiol (2008) 2.06
Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria. Eur Heart J (2008) 2.05
Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm (2009) 2.00
Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet (2013) 1.81
Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol (2010) 1.62
Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates. Hum Pathol (2005) 1.57
Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur Heart J (2006) 1.56
Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol (2002) 1.54
Electrocardiographic pattern in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol (2009) 1.50
Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification. J Cardiovasc Electrophysiol (2013) 1.49
Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation (2005) 1.47
Investigating the mechanism of chromosomal deletion: characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene. Genomics (2002) 1.30
Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol (2011) 1.25
Mutations in the area composita protein αT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy. Eur Heart J (2012) 1.20
Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med (2009) 1.18
Analysis of 22 deletion breakpoints in dystrophin intron 49. Hum Genet (2002) 1.17
Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy: comparison of 3D standard electroanatomical voltage mapping and contrast-enhanced cardiac magnetic resonance. Circ Arrhythm Electrophysiol (2011) 1.14
Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro. BMC Med Genet (2007) 1.11
Computational reconstruction of the human skeletal muscle secretome. Proteins (2006) 1.09
Genomic expression during human myelopoiesis. BMC Genomics (2007) 1.02
REEF: searching REgionally Enriched Features in genomes. BMC Bioinformatics (2006) 0.98
A multistep bioinformatic approach detects putative regulatory elements in gene promoters. BMC Bioinformatics (2005) 0.97
Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Arrhythm Electrophysiol (2013) 0.93
Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women. Am J Cardiol (2008) 0.92
Arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol (2012) 0.91
The binding of the RyR2 calcium channel to its gating protein FKBP12.6 is oppositely affected by ARVD2 and VTSIP mutations. Biochem Biophys Res Commun (2002) 0.91
Identification and characterization of heart-specific splicing of human neurexin 3 mRNA (NRXN3). Biochem Biophys Res Commun (2002) 0.90
TRAM (Transcriptome Mapper): database-driven creation and analysis of transcriptome maps from multiple sources. BMC Genomics (2011) 0.90
The p.A897KfsX4 frameshift variation in desmocollin-2 is not a causative mutation in arrhythmogenic right ventricular cardiomyopathy. Eur J Hum Genet (2010) 0.89
Mediterranean Fin Whales (Balaenoptera physalus) Threatened by Dolphin MorbilliVirus. Emerg Infect Dis (2015) 0.89
Denaturing HPLC-based approach for detecting RYR2 mutations involved in malignant arrhythmias. Clin Chem (2004) 0.88
Motif discovery in promoters of genes co-localized and co-expressed during myeloid cells differentiation. Nucleic Acids Res (2008) 0.88
Detecting seeded motifs in DNA sequences. Nucleic Acids Res (2005) 0.87
Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening. Circulation (2011) 0.87
Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities. Europace (2007) 0.87
Autonomic profile and arrhythmic risk stratification after surgical repair of tetralogy of Fallot. Am Heart J (2004) 0.85
Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes. Eur J Hum Genet (2003) 0.85
Desmin mutations and arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol (2012) 0.84
Heart rate variability in arrhythmogenic right ventricular cardiomyopathy correlation with clinical and prognostic features. Pacing Clin Electrophysiol (2002) 0.83
Genetics of arrhythmogenic right ventricular cardiomyopathy. Curr Opin Cardiol (2002) 0.83
From molecular mechanisms of cardiac development to genetic substrate of congenital heart diseases. Future Cardiol (2010) 0.83
Arrhythmogenic cardiomyopathy: a disease of intercalated discs. Cell Tissue Res (2014) 0.83
Exercise-induced normalization of right precordial negative T waves in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol (2013) 0.82
Functional analysis reveals splicing mutations of the CASQ2 gene in patients with CPVT: implication for genetic counselling and clinical management. Hum Mutat (2011) 0.81
R25C mutation in the NKX2.5 gene in Italian patients affected with non-syndromic and syndromic congenital heart disease. J Cardiovasc Med (Hagerstown) (2013) 0.81
Identification of a PKP2 gene deletion in a family with arrhythmogenic right ventricular cardiomyopathy. Eur J Hum Genet (2013) 0.81
Late-onset arrhythmogenic right ventricular cardiomyopathy. J Cardiovasc Med (Hagerstown) (2006) 0.80
Novel genes, possibly relevant for molecular diagnosis or therapy of human rhabdomyosarcoma, detected by genomic expression profiling. Gene (2005) 0.79
Gender differences and role of pregnancy in the history of post-surgical women affected by tetralogy of Fallot. PLoS One (2012) 0.79
Characterization of a novel human gene containing ANK repeats and ARM domains. Biochem Biophys Res Commun (2004) 0.77
Long-term follow-up of the signal-averaged ECG in arrhythmogenic right ventricular cardiomyopathy: correlation with arrhythmic events and echocardiographic findings. Europace (2006) 0.77